considerable dissatisfaction has been expressed over the fda 's cardio-renal advisory panel 's recommendation on may 29 , 1987 that approval of rt-pa as a thrombolytic agent for the treatment of acute myocardial infarction be delayed .
C0018787
cardio
C0155626
acute myocardial infarction